Background: Leukemia is a malignant neoplasm of the hematopoietic stem cells.
Introduction
Hematological malignancy (leukemia) is a malignant neoplasm of the hematopoietic stem cells characterized by diffuse replacement of the bone marrow and/or peripheral blood by neoplastic cells. It was identified as a separate malignancy in 1889. 1 Leukemia is part of a broader group of neoplasms which affect the blood, bone marrow and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues. 2, 3 Examination of the peripheral blood smear is an inexpensive but powerful diagnostic tool in both children and adults suffering from Leukemia. It provides rapid, reliable access to information about a variety of hematologic disorders. 4 The role of the blood smear in the diagnosis of leukemia and lymphoma is to suggest a likely diagnosis or range of diagnoses, to indicate which additional tests should be performed and to provide a morphologic context without which immune-phenotyping and other sophisticated investigations cannot be interpreted. 4 Peripheral blood analysis by complete blood count and thin smear analysis are first steps to detect most hematologic malignancies which have emerged as a major cause of morbidity and mortality. 4 The diagnosis involves a multiparameter approach including morphologic examination and phenotypic or genotypic studies. 5 However; the smear offers a window into the functional status of the bone marrow, the factory producing all blood elements. Review of the smear is an important adjunct to other clinical data. In some cases, the peripheral smear alone is sufficient to establish a diagnosis. 4 This study has been done to find out the pattern of leukemia, its clinicepidemiological profile and hematological features. 
Materials and Methods

Discussion
Laboratory diagnosis of acute leukemia in modern hematology practice is increasingly relying on guidelines that require the availability of relatively expensive machines. 5 Therefore, where these expensive machines are not available, the laboratory diagnosis would mostly depend on more basic laboratory techniques that should at least include complete blood count (CBC) and peripheral blood morphology, followed by cytochemistry. 5, 6 For the diagnosis of AML/ALL, FAB classification of acute leukemia should be applied in under-resourced laboratories where the only available routine techniques for diagnosis are morphology and cytochemical stains. 5, 6 In the WHO classification of acute leukemia, the diagnosis is based on an arbitrary cut-off point of 20% blasts as a percentage of bone marrow total or nonerythroid cells or as a percentage of peripheral blood cells. 7 This exact percent is also applied nowadays in underresourced laboratories where the FAB classification is used. 8 This 20% blasts cut-off point seems to be universally accepted and for the time being, it represents the best known tool for defining acute leukemia.
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CML is often suspected on the basis of a complete blood count which shows increased granulocytes of all types, typically including mature myeloid cells. Basophils and eosinophils are almost universally increased. 10 The diagnosis of CML is basically based on the pathologic findings of peripheral blood and Philadelphia chromosome in bone marrow cells.
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CLL is usually first suspected by the presence of a lymphocytosis, an increase in one type of white blood cell, on a complete blood count (CBC) test. This feature is an incidental finding on a routine outpatient department visit. Most often the lymphocyte count is greater than 4000 cells per microliter of blood, but can be much higher. The presence of a lymphocytosis in an elderly individual should raise strong suspicion for CLL. 12, 13 This study includes those cases which were diagnosed on the basis of peripheral smear.
Patterns of leukemia
In this study, out of total 52 cases studied, based on morphology and cytochemistry, acute leukemia comprised of 34 cases and 14 cases were of chronic leukemia. Diagnosis of AML and ALL was made in 19 and 4 cases respectively. Diagnosis of CML and CLL/PLL could be possible in 9 and 4 cases respectively. Only acute leukemia (AL) was made in 11 cases. A study conducted by Ghartimagar Among FAB subtypes of AML; the commonest was M2, followed by M1, M4 and M3 in the study conducted by Ghartimagar D et al. 14 The other study conducted by D" Costa G et al. also
showed M1 and M2 to be comprised of maximum cases, followed by M3 and M4.
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Age range in all types of leukemia
The overall age range for all the hematological malignancy was from 2-90 years and mean age was 37.6 year in this study. Similarly in the study done by Kulshrestha R et al., the age range was from 11 day old to 81 years old. 16 In the study done by Weldestsadik AT et al., the mean age for the same was 42 years. 15 Similarly, in the study conducted by D"
Costa G et al., the youngest patient of the series was three weeks aged female and the oldest patient was eighty years old. 18 These findings are consistent with our study.
Male: Female ratio in all types of leukemia
In this study, 54% were males and 46% were females. Similarly in the study conducted by Kulshrestha R et al., male preponderance was observed, with M: F ratio of 1.8:1. 16 Males were affected more by leukemia than females in a ratio of 1.2:1. 15 Male to female ratio was 1.4:1 in the study conducted by Idrish M et al. 17 In the study by D"costa G et al. also, the overall M: F ratio was 2.7:1. 18 These findings are consistent with our study.
Age range and mean age of Acute Myeloid Leukemia
The incidence of AML increases with age; the median age at diagnosis is 63 years.
AML accounts for about 90% of all acute leukemias in adults, but is rare in children.
AML is slightly more common in men, with a male: female ratio of 1.3:1. 15 The age of patients with AML ranged from 2-82 years with a mean of 38 years in a study conducted by Ghartimagar D et al. 14 This finding is consistent with our study. 14 Various studies showed that CML is common in males than in females. 15, 16, 18 In the study done by Provan D et al., the male to female ratio was 1.4:1 and appears more common in the elderly with a median age at diagnosis of 65 years. 19 However, in the study done by D" Costa G et al. the oldest patient diagnosed with CML was 80 years old. 18 Mean age of CML in this study was 49 years and male predominance was seen, as observed in other studies. [14] [15] [16] 18 Organomegaly was the most common presenting clinical feature. Most patients are diagnosed during the chronic phase which is most often asymptomatic. These findings are consistent with the study done by Besa EC et al. 20 Mean hemoglobin, TLC and platelet count was found to be 8.8 gm/dl, 62,777 /mm 3 and 1,46,222/mcl respectively in this study in a case of CML. Similarly, the total count of more than 1,00,000/mm 3 was a more frequent finding in CML in the study done by D" Costa G. 18 All patients with CML had high WBC and majority had anemia and high platelets in one more study.
14 Chronic Lymphocytic Leukemia CLL is a disease of adults. Most (> 75%) people newly diagnosed with CLL are over the age of 50, and the majority are men. 12, 13 This finding is similar to the finding seen in our study. However, in rare cases, it can occur in teenagers and occasionally in children (inherited). Most people are diagnosed without symptoms as the result of a routine blood test that returns a high white blood cell count, but, as it advances, CLL results in swollen lymph nodes, enlarged spleen, and liver, and eventually anemia and infections. 12, 13, 21 In this study also, the most common clinical manifestation was lymphadenopathy.
In this study; most of the cases were clinically diagnosed as anemia, fever, organomegaly and pancytopenia. However, only 13 cases were clinically diagnosed as hematological malignancy and in 8 cases, clinical diagnosis was not provided.
Thus, peripheral smear in under resourced laboratory like ours has a significant role in the diagnosis of hematological malignancies even when clinically the diagnosis could not be made. 
Conclusion
